Successful management of an arteriovenous malformation with trametinib in a patient with capillary-malformation arteriovenous malformation syndrome and cardiac compromise.
Pediatr Dermatol
; 39(2): 316-319, 2022 Mar.
Article
en En
| MEDLINE
| ID: mdl-35014097
ABSTRACT
Capillary malformation-arteriovenous malformation (CM-AVM) syndrome is an autosomal dominant condition characterized by multifocal, noncontiguous pink patches on the skin that often have a surrounding pale halo. In some cases, an association with a fast flow, arteriovenous malformation (AVM) can be identified. Here, we describe a case report of a 16-year-old woman with CM-AVM syndrome and significant cardiac compromise successfully treated with trametinib, a mitogen-activated protein kinase (MEK) inhibitor.
Palabras clave
Texto completo:
1
Base de datos:
MEDLINE
Asunto principal:
Malformaciones Arteriovenosas
/
Mancha Vino de Oporto
Tipo de estudio:
Prognostic_studies
Idioma:
En
Revista:
Pediatr Dermatol
Año:
2022
Tipo del documento:
Article